Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding MST-188 and vaso-occlusive crisis, while a new version number has been added.SummaryDifference11%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.